+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Induced Pluripotent Stem Cells Production Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 250 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5916008
Description Jump to:
The global induced pluripotent stem cells market is experiencing a dynamic transformation with a select group of companies dedicating themselves to providing life science reagents and products. While numerous players, both large-scale and regional, participate in the induced pluripotent stem cells market, a few stand out with their exclusive focus on delivering high-quality products. This specialization not only ensures superior product quality but also fosters customer loyalty and establishes a robust distribution network that extends worldwide.

Rising Investments in Research and Development

The ever-increasing investments by companies in life sciences research and development present promising growth prospects. Companies that supply tools and products to cater to the research needs of healthcare providers and research institutes can anticipate stable returns. Over the past years, substantial investments in basic-level research, primarily by research organizations and academic institutes, have led to a deeper understanding of the fundamental pathways associated with induced pluripotent stem cells and their implications in disease development. This newfound knowledge raises more questions about biology, disease causation, and potential diagnostics and treatments.

Induced pluripotent stem cells exhibit a gene expression signature similar to that of embryonic stem cells, showcasing both pluripotency and self-renewal capabilities. As researchers delve deeper into these pathways, the complexity of products requested has grown, reflecting an improved understanding of fundamental pathways and the discovery of new ones.

Adapting to the Changing Landscape

Manufacturers of research products must stay aligned with the latest developments to meet the evolving requirements of the life sciences industry. The ability to provide cutting-edge solutions is crucial as researchers continually push the boundaries of knowledge.

North America Leading the Way

North America is poised to take the lead in the global induced pluripotent stem cells market, driven by a surge in research and clinical trials. Recent advancements in induced pluripotent stem cells technology, particularly in North American research institutes, have ensured a steady supply of functional cells for pre-clinical drug screening. Induced pluripotent stem cells offer a unique platform for disease modeling on a patient-by-patient basis, allowing for a deep understanding of disease progression and individualized pharmacological drug screening.

The region's focus on micromedicine enables the analysis of drug effectiveness at the individual patient level, while high-throughput drug toxicity screenings using human iPSC-derived cardiomyocytes are becoming commonplace. Ongoing research activities in North America are expected to attract future investments in the induced pluripotent stem cells market.

Europe's Growing Role

Europe is gearing up for significant participation in the induced pluripotent stem cells market, buoyed by the growth of the contract research industry. The region has become a hub for biopharmaceutical companies, both small and large, and relies on contract research organizations and clinical services for research and development operations. Outsourcing of iPSC trials has streamlined drug approval processes, ensuring Europe's continued prominence in the global induced pluripotent stem cells market.

Induced Pluripotent Stem Cells Market Segmentation:

Cell Type

  • Hepatocytes
  • Fibroblasts
  • Keratinocytes
  • Neurons
  • Others

Application

  • Drug Development
  • Regenerative Medicine
  • Toxicity Testing

End User

  • Academic and Research Institutes
  • Biotechnology Companies

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding China (APEC)
  • China
  • Middle East and Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Induced Pluripotent Stem Cells Production Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Induced Pluripotent Stem Cells Production Market Outlook, 2018 - 2031
3.1. Global Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Instruments/Devices
3.1.1.2. Automated Platforms
3.1.1.3. Consumables & Kits
3.1.1.3.1. Media
3.1.1.3.2. Kits
3.1.1.3.3. Others
3.1.1.4. Services
3.2. Global Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Manual
3.2.1.2. Automated
3.3. Global Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Reprogramming
3.3.1.2. Cell Culture
3.3.1.3. Cell Characterization/Analysis
3.3.1.4. Engineering
3.3.1.5. Others
3.4. Global Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Drug Development and Discovery
3.4.1.2. Regenerative Medicine
3.4.1.3. Toxicology Studies
3.4.1.4. Others
3.5. Global Induced Pluripotent Stem Cells Production Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Induced Pluripotent Stem Cells Production Market Outlook, 2018 - 2031
4.1. North America Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Instruments/Devices
4.1.1.2. Automated Platforms
4.1.1.3. Consumables & Kits
4.1.1.3.1. Media
4.1.1.3.2. Kits
4.1.1.3.3. Others
4.1.1.4. Services
4.2. North America Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Manual
4.2.1.2. Automated
4.3. North America Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Reprogramming
4.3.1.2. Cell Culture
4.3.1.3. Cell Characterization/Analysis
4.3.1.4. Engineering
4.3.1.5. Others
4.4. North America Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Drug Development and Discovery
4.4.1.2. Regenerative Medicine
4.4.1.3. Toxicology Studies
4.4.1.4. Others
4.5. North America Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Induced Pluripotent Stem Cells Production Market Outlook, 2018 - 2031
5.1. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Instruments/Devices
5.1.1.2. Automated Platforms
5.1.1.3. Consumables & Kits
5.1.1.3.1. Media
5.1.1.3.2. Kits
5.1.1.3.3. Others
5.1.1.4. Services
5.2. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Manual
5.2.1.2. Automated
5.3. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Reprogramming
5.3.1.2. Cell Culture
5.3.1.3. Cell Characterization/Analysis
5.3.1.4. Engineering
5.3.1.5. Others
5.4. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Drug Development and Discovery
5.4.1.2. Regenerative Medicine
5.4.1.3. Toxicology Studies
5.4.1.4. Others
5.5. Europe Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.2. Germany Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
5.5.1.3. Germany Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
5.5.1.4. Germany Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.5. U.K. Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
5.5.1.8. U.K. Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.9. France Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.10. France Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
5.5.1.11. France Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
5.5.1.12. France Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.13. Italy Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.14. Italy Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
5.5.1.16. Italy Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.17. Turkey Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.18. Turkey Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
5.5.1.19. Turkey Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
5.5.1.20. Turkey Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.21. Russia Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.22. Russia Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
5.5.1.24. Russia Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.25. Rest of Europe Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.26. Rest of Europe Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
5.5.1.27. Rest of Europe Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
5.5.1.28. Rest of Europe Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, 2018 - 2031
6.1. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Instruments/Devices
6.1.1.2. Automated Platforms
6.1.1.3. Consumables & Kits
6.1.1.3.1. Media
6.1.1.3.2. Kits
6.1.1.3.3. Others
6.1.1.4. Services
6.2. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Manual
6.2.1.2. Automated
6.3. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Reprogramming
6.3.1.2. Cell Culture
6.3.1.3. Cell Characterization/Analysis
6.3.1.4. Engineering
6.3.1.5. Others
6.4. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Drug Development and Discovery
6.4.1.2. Regenerative Medicine
6.4.1.3. Toxicology Studies
6.4.1.4. Others
6.5. Asia Pacific Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.2. China Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
6.5.1.3. China Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
6.5.1.4. China Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
6.5.1.8. Japan Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.9. South Korea Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.10. South Korea Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
6.5.1.11. South Korea Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
6.5.1.12. South Korea Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.13. India Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.14. India Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
6.5.1.15. India Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
6.5.1.16. India Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.17. Southeast Asia Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.18. Southeast Asia Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
6.5.1.19. Southeast Asia Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
6.5.1.20. Southeast Asia Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Induced Pluripotent Stem Cells Production Market Outlook, 2018 - 2031
7.1. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Instruments/Devices
7.1.1.2. Automated Platforms
7.1.1.3. Consumables & Kits
7.1.1.3.1. Media
7.1.1.3.2. Kits
7.1.1.3.3. Others
7.1.1.4. Services
7.2. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
7.2.1.1. Manual
7.2.1.2. Automated
7.3. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Reprogramming
7.3.1.2. Cell Culture
7.3.1.3. Cell Characterization/Analysis
7.3.1.4. Engineering
7.3.1.5. Others
7.4. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Drug Development and Discovery
7.4.1.2. Regenerative Medicine
7.4.1.3. Toxicology Studies
7.4.1.4. Others
7.5. Latin America Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.2. Brazil Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
7.5.1.4. Brazil Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
7.5.1.5. Mexico Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.6. Mexico Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
7.5.1.8. Mexico Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
7.5.1.9. Argentina Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.10. Argentina Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
7.5.1.11. Argentina Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
7.5.1.12. Argentina Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
7.5.1.15. Rest of Latin America Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
7.5.1.16. Rest of Latin America Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, 2018 - 2031
8.1. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Instruments/Devices
8.1.1.2. Automated Platforms
8.1.1.3. Consumables & Kits
8.1.1.3.1. Media
8.1.1.3.2. Kits
8.1.1.3.3. Others
8.1.1.4. Services
8.2. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Manual
8.2.1.2. Automated
8.3. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Reprogramming
8.3.1.2. Cell Culture
8.3.1.3. Cell Characterization/Analysis
8.3.1.4. Engineering
8.3.1.5. Others
8.4. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Drug Development and Discovery
8.4.1.2. Regenerative Medicine
8.4.1.3. Toxicology Studies
8.4.1.4. Others
8.5. Middle East & Africa Induced Pluripotent Stem Cells Production Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
8.5.1.4. GCC Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
8.5.1.5. South Africa Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.6. South Africa Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
8.5.1.7. South Africa Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
8.5.1.8. South Africa Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
8.5.1.9. Egypt Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
8.5.1.12. Egypt Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
8.5.1.13. Nigeria Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
8.5.1.15. Nigeria Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
8.5.1.16. Nigeria Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Induced Pluripotent Stem Cells Production Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Induced Pluripotent Stem Cells Production Market by Process, Value (US$ Bn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Induced Pluripotent Stem Cells Production Market by Workflow, Value (US$ Bn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Induced Pluripotent Stem Cells Production Market by Application, Value (US$ Bn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Workflow vs By Process Heatmap
9.2. Manufacturer vs By Process Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Lonza
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Axol Biosciences Ltd.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Evotec
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Hitachi Ltd.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Merck KGaA
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. REPROCELL Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Fate Therapeutic
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Thermo Fisher Scientific, Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Applied StemCell Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • LONZA
  • AXOL BIOSCIENCES LTD
  • EVOTEC
  • HITACHI LTD
  • REPROCELL INC
  • FATE THERAPEUTICS.
  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA (MILLIPORESIGMA)
  • STEMCELLFACTORY III
  • APPLIED STEMCELL INC.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Induced Pluripotent Stem Cells Production Market Analysis & Forecast to 2024-2034 - Product Image

Induced Pluripotent Stem Cells Production Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Global Induced Pluripotent Stem Cells Market by Derived Cell Type, by Application, by End-User, and By Region - Product Image

Global Induced Pluripotent Stem Cells Market by Derived Cell Type, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024 - Product Image

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Induced Pluripotent Stem Cell (iPSC) - Global Strategic Business Report - Product Image

Induced Pluripotent Stem Cell (iPSC) - Global Strategic Business Report

  • Report
  • 349 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.